1. Home
  2. MURA vs UFG Comparison

MURA vs UFG Comparison

Compare MURA & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • UFG
  • Stock Information
  • Founded
  • MURA 2013
  • UFG 2021
  • Country
  • MURA Ireland
  • UFG Singapore
  • Employees
  • MURA N/A
  • UFG N/A
  • Industry
  • MURA
  • UFG Oil Refining/Marketing
  • Sector
  • MURA
  • UFG Energy
  • Exchange
  • MURA Nasdaq
  • UFG Nasdaq
  • Market Cap
  • MURA 36.0M
  • UFG 36.3M
  • IPO Year
  • MURA N/A
  • UFG 2025
  • Fundamental
  • Price
  • MURA $2.09
  • UFG $1.20
  • Analyst Decision
  • MURA Buy
  • UFG
  • Analyst Count
  • MURA 2
  • UFG 0
  • Target Price
  • MURA $6.00
  • UFG N/A
  • AVG Volume (30 Days)
  • MURA 106.1K
  • UFG 624.2K
  • Earning Date
  • MURA 11-04-2025
  • UFG 10-28-2025
  • Dividend Yield
  • MURA N/A
  • UFG N/A
  • EPS Growth
  • MURA N/A
  • UFG N/A
  • EPS
  • MURA N/A
  • UFG 0.01
  • Revenue
  • MURA N/A
  • UFG $195,620,824.00
  • Revenue This Year
  • MURA N/A
  • UFG $31.30
  • Revenue Next Year
  • MURA N/A
  • UFG $24.99
  • P/E Ratio
  • MURA N/A
  • UFG $232.38
  • Revenue Growth
  • MURA N/A
  • UFG 49.71
  • 52 Week Low
  • MURA $0.95
  • UFG $0.77
  • 52 Week High
  • MURA $4.74
  • UFG $11.00
  • Technical
  • Relative Strength Index (RSI)
  • MURA 52.55
  • UFG 33.58
  • Support Level
  • MURA $2.06
  • UFG $1.02
  • Resistance Level
  • MURA $2.10
  • UFG $1.56
  • Average True Range (ATR)
  • MURA 0.01
  • UFG 0.13
  • MACD
  • MURA 0.00
  • UFG 0.18
  • Stochastic Oscillator
  • MURA 66.67
  • UFG 54.31

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

Share on Social Networks: